Tag archive for ‘Elan Corporation’
Nir Eyal On Tuesday, February 28th, 2017

Perrigo shares down 10% after company reports loss, sells Tysabri Drug Royalties

  Perrigo announced on Monday that it had signed a definitive agreement to divest its rights to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri (natalizumab) to RPI Finance More...

Globes On Thursday, June 20th, 2013

Seth Klarman dilutes his shares in the Elan pharmaceuticals corporation

– Klarman’s private investment group TEST3, Baupost, has sold off two million shares in the Eire based pharmaceuticals group, earning his company an estimated $5.7million on the deal, while More...

Wordpress site Developed by Fixing WordPress Problems